U.K. | Science and Enterprise

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
about 20 hours ago
New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
about 20 hours ago
I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
about 2 days ago
Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
about 3 days ago
A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
about 3 days ago

Lightweight AI Chip Designer Raises $2.8M in Seed Funds

By Alan, on November 24th, 2020%

A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems. . . . → Read More: Lightweight AI Chip Designer Raises $2.8M in Seed Funds

Trial Assesses Remote Drug-Phone Blood Pressure Mgmt

By Alan, on November 19th, 2020%

A clinical trial is testing a combination of smartphone reporting and medication to help individuals personalize their blood pressure therapy. . . . → Read More: Trial Assesses Remote Drug-Phone Blood Pressure Mgmt

What to Know About Indefinite Leave To Remain Visas

By Alan, on November 17th, 2020%

If you’ve been living or studying in the UK for a minimum of five years, you are eligible to apply for indefinite leave to remain. . . . → Read More: What to Know About Indefinite Leave To Remain Visas

200M Covid-19 Vaccine Doses Donated to Int’l Effort

By Alan, on October 28th, 2020%

Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide. . . . → Read More: 200M Covid-19 Vaccine Doses Donated to Int’l Effort

Covid-19 Vaccine Challenge Trial Underway

By Alan, on October 20th, 2020%

Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines. . . . → Read More: Covid-19 Vaccine Challenge Trial Underway

Individual Cells Explored with Virtual Reality

By Alan, on October 13th, 2020%

A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions. . . . → Read More: Individual Cells Explored with Virtual Reality

Infographic – Immigrants Boost U.S. Nobel Prizes

By Alan, on October 10th, 2020%

The U.S. dominates Nobel prizes in the sciences — physics, chemistry, medicine, and economics — and immigrants to the U.S. contribute a large chunk of those awards. . . . → Read More: Infographic – Immigrants Boost U.S. Nobel Prizes

Skeletal Stem Cells Enhanced for Bone Repair

By Alan, on September 21st, 2020%

Researchers in the U.K. created a bandage with enhanced human skeletal stem cells that in lab mice repairs simulated skull defects. . . . → Read More: Skeletal Stem Cells Enhanced for Bone Repair

Mental Health Drug Company Raises $127.5M in IPO

By Alan, on September 18th, 2020%

A company developing a drug for depression based on synthesized compounds in hallucinogenic substances is raising $127.5 million in its initial public stock offer. . . . → Read More: Mental Health Drug Company Raises $127.5M in IPO

Point-of-Care Covid-19 Diagnostic Shows High Accuracy

By Alan, on September 18th, 2020%

A test for SARS-CoV-2 viruses in humans is shown in field tests to return diagnostic results in 90 minutes with accuracy comparable to the gold-standard RT-PCR test. . . . → Read More: Point-of-Care Covid-19 Diagnostic Shows High Accuracy

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise